LamivudineTabletsReverse Transcriptase InhibitorsHepatitis B, ChronicTablets, Enteric-CoatedOrganophosphonatesHepatitis B virusAntiviral AgentsHepatitis B e AntigensAdenineAnti-HIV AgentsDrug Resistance, ViralZidovudineStavudineHepatitis BChemistry, PharmaceuticalDideoxynucleosidesDrug Therapy, CombinationExcipientsNevirapineHIV InfectionsDrug CompoundingDNA, ViralAlanine TransaminaseBenzoxazinesDelayed-Action PreparationsHepatitis B Surface AntigensViral LoadTechnology, PharmaceuticalDidanosineIndinavirMethylcelluloseHIV-1Therapeutic EquivalencyPyrimidinonesTreatment OutcomePowdersNucleosidesOxazinesDrug Resistance, Multiple, ViralAdministration, OralHepatitis B AntibodiesAntiretroviral Therapy, Highly ActiveGene Products, polSolubilityLopinavirTreatment FailureNelfinavirZalcitabineHardnessRitonavirGuanineMutationHIV Reverse TranscriptaseCD4 Lymphocyte CountLiver TransplantationDrug CombinationsInterferon-alphaRecurrenceDouble-Blind MethodDideoxynucleotidesDrug Administration ScheduleHIV Protease InhibitorsDrug StabilityLubricantsArea Under CurveHepatitis B Core AntigensDosage FormsCapsulesLiver CirrhosisRNA, ViralVirus ActivationCytidine TriphosphateArabinofuranosyluracilImmunoglobulinsInfectious Disease Transmission, VerticalCellulosePovidoneCross-Over StudiesPolyethylene Glycols2-AminopurineBiological AvailabilityHardness TestsAdministration, BuccalTime FactorsAnti-Retroviral AgentsDrug Resistance, Microbial